Trends in pharmacological sciences, 14(10), 360-366 (1993-10-01)
The numerous and widespread effects of adenosine provide both an opportunity for the development of novel therapeutic agents acting via adenosine receptors and the challenge of achieving selectivity of action. The feasibility of achieving selectivity is enhanced if receptor subtypes
British journal of pharmacology, 109(1), 3-5 (1993-05-01)
The cardiovascular effects of N6-2-(4-aminophenyl)ethyladenosine (APNEA), which when radiolabelled with 125I shows high affinity for the newly described adenosine A3 receptor, have been investigated in the angiotensin II-supported circulation of the pithed rat. APNEA induces hypotensive responses which are unaffected
Adenosine A3 receptors: two into one won't go.
A M Carruthers et al.
Trends in pharmacological sciences, 14(8), 290-291 (1993-08-01)
